Remimazolam
Back to searchMolecule Structure
Scientific Name
Remimazolam
Description of the Drug
Remimazolam is an ultra short-acting benzodiazepine used for the induction and maintenence of procedural sedation during short procedures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12404
http://www.drugbank.ca/drugs/DB12404
Brand Name(s)
Byfavo
Company Owner(s)
Acacia Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL846435 |
| Human Metabolome Database | HMDB0304851 |
| DrugBank | DB12404 |
| PubChem: Thomson Pharma | 14832697 |
| PubChem | 9867812 |
| Nikkaji | J3.241.163K |
| DrugCentral | 5400 |
| ChemicalBook | CB32627691 |
| rxnorm | REMIMAZOLAM |
| ZINC | ZINC000003927450 |
